trial

Pain and Schizophrenia

NCTId NCT01244542
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Terminated
Enrollment 83 (actual)
Sponsored by University Hospital, Strasbourg, France
Primary completion 2015-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
83 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2011-08
Primary completion
2015-01
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
unpleasant stimuli

Sponsors

University Hospital, Strasbourg, FranceLead Sponsor

Investigators

1
Anne GIERSCH, MD, PhDStudy Director

Sites

5 total
Besançon, FranceErstein, FranceStrasbourg, FranceStrasbourg, FranceStrasbourg, France

Facts & assertions

4 sourced
Enrollment
83
Phase
NA
Primary Completion Date
2015-01
Status
TERMINATED
relationships
The graph out of here
drug
unpleasant stimuli
drug
lead_sponsor
University Hospital, Strasbourg, France
company
indication
Pain
indication
Pain
indication
Schizophrenia
indication
investigator
Anne GIERSCH, MD, PhD
person